Great Valley Advisor Group, Inc. Biomarin Pharmaceutical Inc Transaction History
Great Valley Advisor Group, Inc.
- $3.45 Billion
- Q2 2024
A detailed history of Great Valley Advisor Group, Inc. transactions in Biomarin Pharmaceutical Inc stock. As of the latest transaction made, Great Valley Advisor Group, Inc. holds 3,754 shares of BMRN stock, worth $263,117. This represents 0.01% of its overall portfolio holdings.
Number of Shares
3,754
Previous 4,287
12.43%
Holding current value
$263,117
Previous $374,000
17.38%
% of portfolio
0.01%
Previous 0.01%
Shares
10 transactions
Others Institutions Holding BMRN
# of Institutions
632Shares Held
185MCall Options Held
1.63MPut Options Held
1.2M-
Black Rock Inc. New York, NY22.7MShares$1.59 Billion0.04% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$1.33 Billion0.03% of portfolio
-
Primecap Management CO Pasadena, CA18.8MShares$1.32 Billion1.14% of portfolio
-
Dodge & Cox San Francisco, CA13.9MShares$976 Million0.72% of portfolio
-
Capital Research Global Investors Los Angeles, CA9.69MShares$679 Million0.18% of portfolio
About BIOMARIN PHARMACEUTICAL INC
- Ticker BMRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 185,824,000
- Market Cap $13B
- Description
- BioMarin Pharmaceutical Inc. develops and commercializes therapies for people with serious and life-threatening rare diseases and medical conditions. Its commercial products include Vimizim, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; Naglazyme, a recombinant form of N-a...